DXR:Daxor Corp Snapshot | Charting | News | Options
$9.74   0.00%  $0.00 NASDAQ 8:00a ET
April 16 '24 		New Studies Prove the Clinical Benefits of Daxor's Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart... GlobeNewswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story
    New Studies Prove the Clinical Benefits of Daxor's Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart Failure Patients For Measurement of Congestion
     GlobeNewswire
    Full Story →

    Headline News
    DAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE SPRING'24 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR'S BLOOD VOLUME DIAGNOSTIC (BVA-100(TM))
    8:00a ET April 15 '24 GlobeNewswire
    Daxor Corporation Announces New Hospital Account at Leading Chicago Hospital
    8:00a ET April 10 '24 GlobeNewswire
    Daxor Corporation to Exhibit at the American College of Cardiology for ACC.24
    8:00a ET April 1 '24 GlobeNewswire
    More News →
    Day  0.00%Week  1.95%Month  16.1%More Charting →
    April 18 '24. Markets Closed.
    Last $9.74
    Day change   0.00%$0.00
    Open $NA
    Gap at open $NA
    Previous close $9.74
    Trading volume NA
    10 Day avg vol. 3,177
    Shares out. 4.8Mil
    Market cap. $46.7Mil
    Trading activity Below Avg.
    Previous data from yesterday, April 18 '24.

    Historical Price Performance
    3 month   2.11% 
    6 month   8.46% 
    1 year   12.04% 
    2 year   13.60% 

    Earnings
    Previous 12m -$0.04
    Next 12m Estimate NM
    P/E ratio 269.3x
    Revenue 0Mil

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2024 All rights reserved.